{"schema_version":"secwatch.filing_event.v1","accession":"0000105770-24-000088","form_type":"8-K","ticker":"WST","cik":"0000105770","company_name":"WEST PHARMACEUTICAL SERVICES INC","filed_at":"2024-12-13T23:59:59+00:00","discovered_at":"2026-05-14T18:03:07.526536+00:00","generated_at":"2026-05-29T03:18:12.083366+00:00","sec_items":["8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"confidence":"high","headline":"West Pharmaceutical authorizes repurchase of up to 550,000 shares","bullets":["Board approved new share repurchase program on Dec 9, 2024, authorizing up to 550,000 shares.","Repurchases may be made on open market or in private transactions under Rule 10b-18.","Program expected to be completed by December 31, 2025.","Existing repurchase program expires at end of 2024.","Repurchase timing and number depend on market conditions."],"urls":{"canonical":"https://secwatch.observer/filing/0000105770-24-000088","json":"https://secwatch.observer/filing/0000105770-24-000088.json","markdown":"https://secwatch.observer/filing/0000105770-24-000088.md","text":"https://secwatch.observer/filing/0000105770-24-000088.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/105770/000010577024000088/0000105770-24-000088-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/105770/000010577024000088/wst-20241209.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-29T03:18:12.083366+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}